Total Payments
$238,349
2024 Payments
$18,330
Companies
4
Transactions
294
Payment Breakdown by Category
Other$134,566 (56.5%)
Travel$55,765 (23.4%)
Consulting$40,036 (16.8%)
Food & Beverage$7,983 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,146 | 52 | 38.2% |
| Travel and Lodging | $55,765 | 132 | 23.4% |
| Honoraria | $43,420 | 19 | 18.2% |
| Consulting Fee | $40,036 | 13 | 16.8% |
| Food and Beverage | $7,983 | 78 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $222,995 | 284 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $15,148 | 8 | $0 (2024) |
| Spark Therapeutics, Inc. | $117.79 | 1 | $0 (2018) |
| Biogen, Inc. | $89.11 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,330 | 9 | BioMarin Pharmaceutical Inc. ($14,335) |
| 2023 | $13,296 | 17 | Alexion Pharmaceuticals, Inc. ($12,804) |
| 2022 | $15,872 | 18 | Alexion Pharmaceuticals, Inc. ($15,697) |
| 2021 | $11,975 | 12 | Alexion Pharmaceuticals, Inc. ($11,975) |
| 2020 | $10,942 | 11 | Alexion Pharmaceuticals, Inc. ($10,942) |
| 2019 | $48,891 | 64 | Alexion Pharmaceuticals, Inc. ($48,744) |
| 2018 | $50,725 | 80 | Alexion Pharmaceuticals, Inc. ($50,518) |
| 2017 | $68,318 | 83 | Alexion Pharmaceuticals, Inc. ($68,318) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Rare Disease | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $100.38 | General |
| Category: Rare Disease | ||||||
| 07/30/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| 05/03/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,466.00 | General |
| Category: Achondroplasia | ||||||
| 02/27/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $615.00 | General |
| Category: Rare Disease | ||||||
| 12/31/2023 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $491.78 | General |
| 08/22/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $820.00 | General |
| Category: Rare Disease | ||||||
| 08/08/2023 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| 07/15/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $95.37 | General |
| Category: Rare Disease | ||||||
| 07/14/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $936.40 | General |
| 07/14/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $329.36 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $76.48 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $39.30 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.30 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| 04/18/2023 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| 03/30/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $287.55 | General |
| 03/30/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.10 | General |
| 03/21/2023 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| 03/16/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.80 | General |
| 03/15/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $61.33 | General |
| Category: Rare Disease | ||||||
About Dr. Howard Saal, M.D
Dr. Howard Saal, M.D is a Clinical Genetics (M.D.) healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801827308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Saal, M.D has received a total of $238,349 in payments from pharmaceutical and medical device companies, with $18,330 received in 2024. These payments were reported across 294 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,146).
Ad
Practice Information
- Specialty Clinical Genetics (M.D.)
- Location Cincinnati, OH
- Active Since 07/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1801827308
Products in Payments
- Strensiq (Drug) $118,335
- STRENSIQ (Biological) $5,447
- VOXZOGO 1.2mg (Drug) $2,466
- LUXTURNA (Biological) $117.79
- SPINRAZA (Biological) $89.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Genetics (M.D.) Doctors in Cincinnati
Robert Hopkin, M.d, M.D
Clinical Genetics (M.D.) — Payments: $481,014
Clinical Genetics (M.D.) $481,014
Gregory Grabowski, M.d, M.D
Clinical Genetics (M.D.) — Payments: $217,274
Clinical Genetics (M.D.) $217,274
Dr. Loren Pena, Md, Phd, MD, PHD
Clinical Genetics (M.D.) — Payments: $59,956
Clinical Genetics (M.D.) $59,956
Nancy Leslie, M.d, M.D
Clinical Genetics (M.D.) — Payments: $32,749
Clinical Genetics (M.D.) $32,749
Dr. Angela Sun, M.d, M.D
Clinical Genetics (M.D.) — Payments: $3,062
Clinical Genetics (M.D.) $3,062
Elizabeth Schorry, M.d, M.D
Clinical Genetics (M.D.) — Payments: $1,362
Clinical Genetics (M.D.) $1,362